Cancer Synoptic Reporting Project Group

Space shortcuts

Page tree

Versions Compared

Old Version 1

changes.mady.by.user Scott Campbell

Saved on

compared with

New Version 2

changes.mady.by.user Scott Campbell

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Suzanne Santamaria Scott Campbell  Jieun Hwang Jim Case  Paul Seegers @george birdsong

@maryedgerton Stefan Dubois Elaine Wooler Laszlo Igali Thomas Ruediger 

02-17-2025 at 16:30 - 17:30 UTC


@brous; @keren Hulkower @ross simpson

Zoom - https://snomed.zoom.us/my/pathologycrg


Meeting Recording (GoogleDrive)


Discussion items

ItemDescriptionOwnerNotesAction
1

Updates:

Scott Campbell 

  1. CAP publication planning
  2. Data conversion work (end of 1st qtr for distribution)
    1. Manuscript update
  3. ICCR update - No updates since last meeting.  Adminstriviation pending...can we increase our meeting frequency?


2

Oslo Meeting - Apirl 6 - 9

Scott Campbell 

  1. Who is planning to attend in person?  Virtually?
  2. Topics
    1. CSRWG wrap up
Next phase(s)? - Scott Campbell follow up with Ian Green on CRG as option.
    1. Histopathology Working CRG launch (Agenda/work plan development)
    2. Histology Quality Working Group
    3. Pathology CRG (general)
  2. Eric Daley, Elaine Wooler, Jim Case, Paul Seegers, Stefan Dubois (question), Thomas (virtual), Georg (virtual), Laszlo (and son?), Ji Eun?, Mary Edgerton , Ekaterina (virtual), Raj Dash


3
Paraganglioma vs. Pheochromocytoma and related findings/disorders

Remaining work

Scott Campbell 

Approximately 100-120 concepts



4

Lymph nodes

Scott Campbell 

716857003 |Hereditary pheochromocytoma and paraganglioma (disorder)|

Can we call this Hereditary paraganglioma?  Pheochromocytoma is subsumed by paraganglioma.

Necrotic nephroblastoma
  1. sentinel vs. non-sentinel
  2. Laterized?


5

tnm descriptors

Scott Campbell 



6

Anatomic locations for margins/tumor extension

Scott Campbell 

4



7

Clinical findings resolution - Still in process

Scott Campbell

This recommendation needs to be solidified by this group

  1. Need to determine the scope/extent of use of current content used in each organization/community of practice.
    1. Content at issue
    2. Recommended plan
    3. Rationale to do change
    4. ID deficiency of existing content
    5. Define implausibility of editing existing
    6. How are you using existing content?
    7. How are you overcoming deficiencies with current content?

  2. Impact of change on your organization?

  3. What is the process for transition?  Needs to be articulated in the briefing note/consultative note

  4. What to do with legacy content...how to handle it?  How convert old content to new representation needs to be articulated...implementation question.

  5. How does this group engage with adoption/transition/implementation?

  6. Make sure that link to implementation guide included.

  7. Discuss approach vs. pre-coordination

View file
nameBriefing note Cancer Synoptic Content (1).docx
height250

5Open items

Scott Campbell 

  1. Lymph node stations lung and esophagus

6CSRWG Future?

Scott Campbell 

Continue Discussion on how to proceed

Metadata uses:

Digital imaging application:
How would this manifest itself? 
Would this be bound to DICOM?
To what level of granularity in the image? Morphology data?  Diagnostic data (IHC?)

AI application.

  1. CSRWG will wrap up by April Business Mtg - 2025
  2. Ongoing working groups
    1. Histology Quality
    2. WSI? - Laszlo Igali favors this
    3. IHC?
    4. Medical synoptics
    5. Artificial Intelligence, pathology and synoptic reporting.  Paul Seegers favors this
    6. Implementation focus?  
      1. Implementation
      2. links to WSI
      3. links to AI
      4. Metadata!


Meeting Files

Attachments




Previous Meetings

Content Report Table
maxResults12
showCommentsCounttrue
spaces@self
labelsmeeting-agenda